Sian Bigora

Chief Development Officer, Processa Pharmaceuticals, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Apr 30, 2026Bought 1,971 shares at $2.71 of Processa Pharmaceuticals, Inc.²
Apr 30, 2026Bought 1,986 shares at $2.69 of Processa Pharmaceuticals, Inc.³
Apr 15, 2026Bought 1,799 shares at $2.97 of Processa Pharmaceuticals, Inc.⁴
Mar 31, 2026Bought 2,107 shares at $2.54 of Processa Pharmaceuticals, Inc.⁵
Jan 1, 2026Exercised options 249 shares of Processa Pharmaceuticals, Inc.⁶
Apr 1, 2025Shares withheld for tax 3,311 shares at $0.41 of Processa Pharmaceuticals, Inc.⁷
Apr 1, 2025Exercised options 15,059 shares of Processa Pharmaceuticals, Inc.⁷
Jul 10, 2024Shares withheld for tax 225 shares at $1.71 of Processa Pharmaceuticals, Inc.⁸
Jul 10, 2024Exercised options 644 shares of Processa Pharmaceuticals, Inc.⁸
Apr 5, 2024Shares withheld for tax 368 shares at $2.79 of Processa Pharmaceuticals, Inc.⁸
Apr 5, 2024Exercised options 1,675 shares of Processa Pharmaceuticals, Inc.⁸
Jan 1, 2024Shares withheld for tax 368 shares at $2.79 of Processa Pharmaceuticals, Inc.⁹
Jan 1, 2024Exercised options 1,675 shares of Processa Pharmaceuticals, Inc.⁹
Aug 5, 2022Exercised options 7,601 shares of Processa Pharmaceuticals, Inc.¹⁰

The numbers on this page point here. Each one links to the record it came from.